Clinical Trial Update: Clinical Study of Raloxifene and Strontium Ranelate in Postmenopausal Osteoporosis [Phase 4]

View source ↗

Summary

Phase 4 clinical study evaluating the combination of raloxifene and strontium ranelate in postmenopausal osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Raloxifene (raloxifene)
• Strontium ranelate (strontium ranelate)

Snippet

Sponsor: University of Valencia | Conditions: Postmenopausal Osteoporosis, Compliance | Phase 4 | Status: COMPLETED